Alphatec Holdings, Inc. (ATEC) is a Medical - Devices company in the Healthcare sector, currently trading at $11.52. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ATEC = $162.02 (+1306.4% from the current price, the stock appears undervalued). Analyst consensus target is ATEC = $23 (+102.5% upside).
Valuation: ATEC trades at a trailing Price-to-Earnings (P/E) of -11.7 (S&P 500 average ~25).
Financials: revenue is $764M, +29.7%/yr average growth. Net income is $143M (loss), growing at +0.7%/yr. Net profit margin is -18.8% (negative). Gross margin is 69.6% (+3.2 pp trend).
Balance sheet: total debt is $620M against $36M equity (Debt-to-Equity (D/E) ratio 17.21, leveraged). Current ratio is 2.06 (strong liquidity). Debt-to-assets is 78.4%. Total assets: $791M.
Analyst outlook: 13 / 16 analysts rate ATEC as buy (81%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 70/100 (Pass), Future 94/100 (Pass), Income 10/100 (Fail).
